Logo image of ODYS

ODYSIGHT.AI INC (ODYS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ODYS - US81063V2043 - Common Stock

3.09 USD
-0.04 (-1.28%)
Last: 11/21/2025, 8:00:02 PM
Fundamental Rating

4

Overall ODYS gets a fundamental rating of 4 out of 10. We evaluated ODYS against 188 industry peers in the Health Care Equipment & Supplies industry. ODYS has a great financial health rating, but its profitability evaluates not so good. ODYS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ODYS has reported negative net income.
ODYS had a negative operating cash flow in the past year.
ODYS had negative earnings in each of the past 5 years.
In the past 5 years ODYS always reported negative operating cash flow.
ODYS Yearly Net Income VS EBIT VS OCF VS FCFODYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

ODYS has a worse Return On Assets (-48.30%) than 64.89% of its industry peers.
Looking at the Return On Equity, with a value of -65.51%, ODYS is in line with its industry, outperforming 45.74% of the companies in the same industry.
Industry RankSector Rank
ROA -48.3%
ROE -65.51%
ROIC N/A
ROA(3y)-45.19%
ROA(5y)-118.61%
ROE(3y)-59.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ODYS Yearly ROA, ROE, ROICODYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K 2K 3K

1.3 Margins

Looking at the Gross Margin, with a value of 18.27%, ODYS is doing worse than 79.79% of the companies in the same industry.
ODYS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ODYS Yearly Profit, Operating, Gross MarginsODYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

8

2. Health

2.1 Basic Checks

ODYS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ODYS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ODYS has been increased compared to 5 years ago.
There is no outstanding debt for ODYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ODYS Yearly Shares OutstandingODYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ODYS Yearly Total Debt VS Total AssetsODYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

ODYS has an Altman-Z score of 2.33. This is not the best score and indicates that ODYS is in the grey zone with still only limited risk for bankruptcy at the moment.
ODYS has a better Altman-Z score (2.33) than 66.49% of its industry peers.
There is no outstanding debt for ODYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.33
ROIC/WACCN/A
WACC8.74%
ODYS Yearly LT Debt VS Equity VS FCFODYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

2.3 Liquidity

A Current Ratio of 6.44 indicates that ODYS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.44, ODYS belongs to the best of the industry, outperforming 84.04% of the companies in the same industry.
ODYS has a Quick Ratio of 6.21. This indicates that ODYS is financially healthy and has no problem in meeting its short term obligations.
ODYS has a Quick ratio of 6.21. This is amongst the best in the industry. ODYS outperforms 88.30% of its industry peers.
Industry RankSector Rank
Current Ratio 6.44
Quick Ratio 6.21
ODYS Yearly Current Assets VS Current LiabilitesODYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

6

3. Growth

3.1 Past

ODYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.34%, which is quite impressive.
The Revenue has grown by 201.97% in the past year. This is a very strong growth!
Measured over the past years, ODYS shows a very strong growth in Revenue. The Revenue has been growing by 83.48% on average per year.
EPS 1Y (TTM)27.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.01%
Revenue 1Y (TTM)201.97%
Revenue growth 3Y83.48%
Revenue growth 5YN/A
Sales Q2Q%-38.28%

3.2 Future

Based on estimates for the next years, ODYS will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.76% on average per year.
Based on estimates for the next years, ODYS will show a quite strong growth in Revenue. The Revenue will grow by 8.52% on average per year.
EPS Next YN/A
EPS Next 2Y18.97%
EPS Next 3Y15.76%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y15.98%
Revenue Next 3Y8.52%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ODYS Yearly Revenue VS EstimatesODYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2025 2026 1M 2M 3M 4M
ODYS Yearly EPS VS EstimatesODYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

0

4. Valuation

4.1 Price/Earnings Ratio

ODYS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ODYS Price Earnings VS Forward Price EarningsODYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ODYS Per share dataODYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as ODYS's earnings are expected to grow with 15.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.97%
EPS Next 3Y15.76%

0

5. Dividend

5.1 Amount

No dividends for ODYS!.
Industry RankSector Rank
Dividend Yield N/A

ODYSIGHT.AI INC

NASDAQ:ODYS (11/21/2025, 8:00:02 PM)

3.09

-0.04 (-1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/dmh
Earnings (Next)N/A N/A
Inst Owners30.75%
Inst Owner Change2.72%
Ins Owners33.47%
Ins Owner Change0%
Market Cap50.55M
Revenue(TTM)2.92M
Net Income(TTM)-9.92M
Analysts82.86
Price Target10.2 (230.1%)
Short Float %0.03%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.33
P/FCF N/A
P/OCF N/A
P/B 3.34
P/tB 3.34
EV/EBITDA N/A
EPS(TTM)-0.95
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.54
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.18
BVpS0.93
TBVpS0.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.3%
ROE -65.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.27%
FCFM N/A
ROA(3y)-45.19%
ROA(5y)-118.61%
ROE(3y)-59.73%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.07%
Cap/Sales 4.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.44
Quick Ratio 6.21
Altman-Z 2.33
F-Score5
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)202.91%
Cap/Depr(5y)378.72%
Cap/Sales(3y)58.41%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.01%
EPS Next YN/A
EPS Next 2Y18.97%
EPS Next 3Y15.76%
EPS Next 5YN/A
Revenue 1Y (TTM)201.97%
Revenue growth 3Y83.48%
Revenue growth 5YN/A
Sales Q2Q%-38.28%
Revenue Next YearN/A
Revenue Next 2Y15.98%
Revenue Next 3Y8.52%
Revenue Next 5YN/A
EBIT growth 1Y-19.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y-3.33%
EBIT Next 5YN/A
FCF growth 1Y-52.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.26%
OCF growth 3YN/A
OCF growth 5YN/A

ODYSIGHT.AI INC / ODYS FAQ

Can you provide the ChartMill fundamental rating for ODYSIGHT.AI INC?

ChartMill assigns a fundamental rating of 4 / 10 to ODYS.


Can you provide the valuation status for ODYSIGHT.AI INC?

ChartMill assigns a valuation rating of 0 / 10 to ODYSIGHT.AI INC (ODYS). This can be considered as Overvalued.


How profitable is ODYSIGHT.AI INC (ODYS) stock?

ODYSIGHT.AI INC (ODYS) has a profitability rating of 0 / 10.